Related references
Note: Only part of the references are listed.Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2017)
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Christopher Acker et al.
Alzheimers & Dementia (2012)
Constitutive secretion of tau protein by an unconventional mechanism
Xiyun Chai et al.
NEUROBIOLOGY OF DISEASE (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
Trans-Synaptic Spread of Tau Pathology In Vivo
Li Liu et al.
PLOS ONE (2012)
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Vanessa Plouffe et al.
PLOS ONE (2012)
Is tau ready for admission to the prion club?
Garth F. Hall et al.
PRION (2012)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Bapineuzumab
Geoffrey A. Kerchner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease
Rakez Kayed
HUMAN VACCINES (2010)
'Prion-Like' Propagation of Mouse and Human Tau Aggregates in an Inducible Mouse Model of Tauopathy
Astrid Sydow et al.
NEURODEGENERATIVE DISEASES (2010)
Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Manuela Polydoro et al.
JOURNAL OF NEUROSCIENCE (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice
Kevin H. J. Park et al.
JOURNAL OF NEUROSCIENCE (2007)
Anti-A beta(42)- and anti-A beta(40)-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model
Y Levites et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Cdk5 is a key factor in tau aggregation and tangle formation in vivo
W Noble et al.
NEURON (2003)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
